Health Care Research
We currently have thress equity research analysts who cover companies leading advancements in biotechnology, medical technologies and pharmaceuticals.
Edward H. Nash
Managing Director
Biotechnology Equity Research
Joseph Pantginis, Ph.D.
Senior Vice President
Biotechnology Equity Research
Biotechnology - Life Sciences
Achillion Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc.
Ardea Biosciences, Inc.
Ariad Pharmaceuticals, Inc.
Catalyst Pharmaceutical Partners Inc.
Celldex Therapeutics, Inc.
Cubist Pharmaceuticals, Inc.
Curis, Inc.
Dendreon Corp.
Exelixis, Inc.
Gilead Sciences, Inc.
Geron Corporation
Halozyme Therapeutics
Ligand Pharmaceuticals, Inc.
Medarex, Inc.
Micromet, Inc.
ONCOLYTICS BIOTECH
Oxigene, Inc.
Pharmassets, Inc.
PolyMedix, Inc.
QRXPHARMA, Ltd.
Regeneron Pharmaceuticals, Inc.
Sangamo Biosciences, Inc.
Starpharma Holdings LTD
SuperGen, Inc.
Vertex Pharmaceuticals, Inc.
Locations
|
Privacy Statement
|
Business Continuity
|
Terms/Conditions
|
Disclosures
|
Third Party Disclosure
|
NASDAQ:MERR
©2009 | Merriman Curhan Ford & Co | All Rights Reserved | Member
FINRA
/
SIPC
